Ambroxol adjuvant treatment of bronchial pneumonia and 90 cases of infant observation.docVIP

 PAGE \* MERGEFORMAT 6 Ambroxol adjuvant treatment of bronchial pneumonia and 90 cases of infant observation [Abstract] Objective To observe the adjuvant treatment of ambroxol in the efficacy of infantile bronchial pneumonia. Methods of fever, cough bronchial pneumonia in infants were randomly divided into two groups. The treatment group were given conventional treatment based on the intravenous drip ambroxol hydrochloride injection 0.6 ~ 0.8 mg / (kg · d, 5% glucose injection 50 ml, day 1. the efficiency of the treatment group was significantly higher than the average time cough, shortness of breath disappearance time, pulmonary rales disappeared significantly shorter time than the control group. Conclusion ambroxol treatment of infantile bronchopneumonia secondary effect is significant. [Keywords:] ambroxol, bronchial pneumonia, in children, clinical observation Bronchial pneumonia is the most common diseases of children, especially common in infants and young children, infants and young children sick with respiratory secretions increase, not easy to cough up sputum, chest signs disappeared slowly. Ambroxol cyclohexylamine bromide, also known as alcohol, the bromine has a new active metabolite for the secretion of abnormal mucus or sputum of acute dysfunction and chronic airway diseases, expectorant treatment, the clinical efficacy and safety have been clinically proven. ambroxol with increased airway surfactant the synthesis and secretion, improve the mucociliary transport system clear role in regulating the secretion of mucus secreting cells and the ratio of the slurry, and promote expectoration, and because the viscosity of sputum decreased infiltration and increased antibiotic antibacterial effect is easy. I Division in the regular anti-infective based on the use of ambroxol hydrochloride intravenous adjuvant treatment of infantile bronchial pneumonia, achieve better results, are as follows. 1 Clinical data 1.1 General Information Select Ja